• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Eli Lilly and Company (LLY)

    -NYSE
    72.40 Down 0.05(0.07%) Dec 19, 4:03PM EST
    |After Hours : 72.40 Down 0.00 (0.00%) Dec 19, 6:51PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 23,113,100   22,603,400   24,286,500  
    Cost of Revenue4,908,100  4,796,500  5,067,900  
    Gross Profit 18,205,000   17,806,900   19,218,600  
    Operating Expenses
    Research Development5,531,300  5,278,100  5,020,800  
    Selling General and Administrative6,606,700  6,839,500  8,058,900  
    Non Recurring177,700  281,100  789,400  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 5,889,300   5,408,200   5,349,500  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes5,889,300  5,408,200  5,349,500  
    Interest Expense -   -   -  
    Income Before Tax5,889,300  5,408,200  5,349,500  
    Income Tax Expense1,204,500  1,319,600  1,001,800  
    Minority Interest -   -   -  
    Net Income From Continuing Ops4,684,800  4,088,600  4,347,700  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 4,684,800   4,088,600   4,347,700  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 4,684,800   4,088,600   4,347,700  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.